Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Jan 25, 2022 12:07pm
242 Views
Post# 34358389

Based on...

Based on......the last published  (Dec 21) Projected Tigris recruitment projections...

...it looks to me like the numbers for Feb were projected to be...

Worst Case ~30    (~48 for April)

Most Likely  ~35     (~ 59 for April)

Best Case ~40        (~70 for April)

I wonder where we are??  which tragectory are we on? 

Would be nice if the owners could get an update.  Hoping that Kellum's new Rolodex (supercharged with 21st century Zoom Meeting technology) is working well.

MM



PS: on the ML trajectory, the magical 90 patients threshold would be achieved in July 2022.  That would represent decision time for Baxter...and potentially a large cash infusion  !








<< Previous
Bullboard Posts
Next >>